🏠 Back to Index

3BBLACKBIO Daily Market Report

Date Range: 2026-08-18 to 2026-08-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Summary table for 3BBLACKBIO Report
Metric Value
Latest closed session 2026-08-26
Latest close 1306.3000
20-session average turnover 22284182.21
Distance from 252-session high 0.00%

Trailing Price Returns

Summary table for 3BBLACKBIO Report
Sessions Return
1 3.48%
5 14.21%
20 N/A
60 N/A
120 N/A
250 N/A

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Summary table for 3BBLACKBIO Report
Archetype Regime Primary horizon Strength First rejection risk
None No current Market Intelligence candidate

Evidence Limits

Fundamental Research

Summary table for 3BBLACKBIO Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth 47.11%
Net margin 41.28%
Return on equity 18.06%
Debt/equity N/A
Operating cash flow/net income 0.90
Free-cash-flow margin 19.00%
Trailing P/E N/A
Price/book 3.11

Source: EODHD retrieved 2026-08-25T23:17:10.205521+00:00.

QA flags: balance_sheet_equation: difference=72568000.00

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.